University Hospitals Birmingham NHS Foundation Trust

Loading results...
View full results list

Medicines A–Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

D

Status	Drug name	NICE TAs	Comments
	Daratumumab	TA510 - Daratumumab monotherapy for treating relapsed and refractory multiple myeloma TA573 - Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma TA897 - Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma TA917 - Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitable	Hospital use only
	Darbepoetin alfa (Aranesp)	TA323 - Erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy	NHSE commissioned renal dialysis. CCG commissioned for use in cancer - NICE TA323.
	Daridorexant (QUVIVIQ®)		TA922: Daridorexant for treating long-term insomnia
	Darolutamide (Nubeqa®)	TA660 - Darolutamide with androgen deprivation therapy for treating hormone-relapsed non-metastatic prostate cancer TA903 - Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer
	Dasatinib (Sprycel®)		For ALL
	Dasatinib tablets	TA425 - Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia TA426 - Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia	Hospital use only
	Daunorubicin injection
	Daunorubicin liposomal injection
	Decitabine injection	TA270 - Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal)
	Deep Blue®		Lifting agent for use during complex EMR/ESD procedures

Building healthier lives